Are Pharmacies the New Dispensary Model? Utah Thinks So
Georgia has captured national attention by allowing medical cannabis to be sold through independent pharmacies. Utah has spent the past six years […]
Georgia has captured national attention by allowing medical cannabis to be sold through independent pharmacies. Utah has spent the past six years […]
On April 23, 2026, the Department of Justice placed FDA-approved marijuana products and marijuana products subject to qualifying state medical licenses into […]
The cannabis industry has spent years waiting for this moment. As federal rescheduling moves forward, so do the opportunities to develop cannabinoid-based […]
Cannabis packaging decisions have downstream consequences for compliance, operations, customer perception, and margins. This article offers a practical framework for evaluating packaging […]
As federal policymakers move toward restricting hemp-derived cannabinoid products, a new state-level effort in Colorado is taking the opposite approach by moving […]
As the U.S. hemp industry braces for potential federal disruption later this year, a new bipartisan bill aims to give states a […]
A letter to California’s Assembly Committee on Business and Professions argues a proposed 10mg THC-per-package cap would eliminate 93% of beverage sales […]
At the recent Business of Cannabis event in New York, Robert Sciarrone, Chief Revenue Officer at Curaleaf, shared an MSO’s insider view […]
California’s medical cannabis market began in 1996 when voters passed Proposition 215 (the Compassionate Use Act), making it the first state to […]
The Most Exciting US Market No cannabis market in the United States has experienced a more compelling growth trajectory over the past […]